Progresses on genetic susceptibility of COVID-19

Yi Chuan. 2023 Nov 20;45(11):963-975. doi: 10.16288/j.yczz.23-215.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes a broad clinical spectrum of coronavirus disease 2019 (COVID-19). Genetic factors might influence susceptibility to the SARS-CoV-2 infection or disease severity. Genome-wide association studies (GWASs) have identified multiple susceptible genes related to COVID-19 phenotypes, providing the scientific basis for the COVID-19 prevention and treatment. In this review, we summarize the recent progresses of COVID-19 susceptible genes, including the GWASs on multiple phenotypes of COVID-19, GWASs of COVID-19 in multiple ethnic populations, GWASs of COVID-19 based on multiple types of genetic variations, and the fine-mapping of the regions surrounding the susceptible genes.

新型冠状病毒(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)感染人体后,个体间存在显著不同的新冠肺炎(corona virus disease 2019,COVID-19)临床症状。机体遗传因素在新冠病毒感染后的临床转归过程中发挥重要的作用。以全基因组关联研究(genome-wide association studies, GWAS)为代表的遗传关联研究方法,已成功鉴定了多个与新冠肺炎相关的易感基因,为新冠肺炎防诊治措施的研发提供了理论基础。本文综述了新冠肺炎遗传易感基因的研究进展,包括多种表型、多个人群、多种遗传变异类型的新冠肺炎全基因组关联研究以及易感基因区域的精细定位研究等,旨在为新冠肺炎遗传易感基因的后续研究提供参考。.

Keywords: COVID-19; SARS-CoV-2; Susceptibility gene.

Publication types

  • Review

MeSH terms

  • COVID-19* / genetics
  • Genetic Predisposition to Disease* / genetics
  • Genome-Wide Association Study*
  • Humans
  • SARS-CoV-2* / genetics